Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Entero Healthcare Solutions's enterprise value is ₹87,074 Mil.
Entero Healthcare Solutions's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ₹3,211 Mil. Therefore, Entero Healthcare Solutions's EV-to-EBITDA for today is 27.12.
The historical rank and industry rank for Entero Healthcare Solutions's EV-to-EBITDA or its related term are showing as below:
NSE:ENTERO'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 15.93 Med: 25.24 Max: 57.64
Current: 27.12
During the past 6 years, the highest EV-to-EBITDA of Entero Healthcare Solutions was 57.64. The lowest was 15.93. And the median was 25.24.
NSE:ENTERO's EV-to-EBITDA is ranked worse than 90% of 100
companies
in the Medical Distribution industry
Industry Median: 8.495
vs NSE:ENTERO: 27.12
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Entero Healthcare Solutions's PE Ratio (TTM) for today is calculated as:
Entero Healthcare Solutions's share price for today is ₹1898.40.
Entero Healthcare Solutions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹28.780.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ENTERO vs MCK, COR, CAH: EV-to-EBITDA Comparison
For the Medical Distribution subindustry, Entero Healthcare Solutions's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Entero Healthcare Solutions EV-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Entero Healthcare Solutions's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Entero Healthcare Solutions's EV-to-EBITDA falls into.
Entero Healthcare Solutions's current Enterprise Value is ₹87,074 Mil.
Entero Healthcare Solutions's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,211 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Entero Healthcare Solutions (NSE:ENTERO) has a EV-to-EBITDA of 27.12 as of Sep. 08, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Entero Healthcare Solutions. This is near median its historical median of 25.24. Over the past decade, Entero Healthcare Solutions' EV-to-EBITDA has ranged from 15.93 to 57.64. According to the industry distribution chart, Entero Healthcare Solutions ranks #90 out of 100 companies in the Medical Distribution industry, placing it in the top 90%.
Is Entero Healthcare Solutions' EV-to-EBITDA too high?
Entero Healthcare Solutions' current EV-to-EBITDA of 27.12 is near median its 10-year median of 25.24. Over the past 10 years, this metric has ranged from a low of 15.93 to a high of 57.64. The Medical Distribution industry median EV-to-EBITDA is 8.50. Entero Healthcare Solutions' value of 27.12 is 219.2% above this industry median. Based on the distribution chart, Entero Healthcare Solutions ranks #90 out of 100 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Entero Healthcare Solutions has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Entero Healthcare Solutions' EV-to-EBITDA compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Entero Healthcare Solutions ranks #90 out of 100 companies for EV-to-EBITDA. This places Entero Healthcare Solutions in the lower half of its industry. The industry median EV-to-EBITDA is 8.50. Entero Healthcare Solutions' value of 27.12 is 219.2% above this benchmark. Historically, Entero Healthcare Solutions' own EV-to-EBITDA has ranged from 15.93 to 57.64 over the past decade. While the company's 10-year median is 25.24 vs. the industry median of 8.50, Entero Healthcare Solutions has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Distribution company?
The median EV-to-EBITDA among Medical Distribution companies is 8.50, based on 100 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Entero Healthcare Solutions's current EV-to-EBITDA of 27.12 is 219.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Entero Healthcare Solutions. For the Medical Distribution industry, the median EV-to-EBITDA is 8.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Entero Healthcare Solutions's current EV-to-EBITDA is 27.12, which is near median its own 10-year median of 25.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entero Healthcare Solutions stock overvalued right now?
Based on GuruFocus' analysis, Entero Healthcare Solutions (NSE:ENTERO) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,760.51, compared to a current price of ₹1,898.40 — trading 7.8% above its estimated fair value. The current EV-to-EBITDA is 27.12, which is near median its 10-year median of 25.24 and 219.2% above the Medical Distribution industry median of 8.50. Entero Healthcare Solutions' overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Entero Healthcare Solutions (NSE:ENTERO), the current EV-to-EBITDA is 27.12 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Entero Healthcare Solutions (NSE:ENTERO) Overvalued in 2026?
Based on GuruFocus' analysis, Entero Healthcare Solutions stock appears to be overvalued.
The current stock price of ₹1,898.40 is trading 7.8% above its estimated GF Value™ of ₹1,760.51.
GuruFocus considers Entero Healthcare Solutions to be Fairly Valued.
Key valuation signals for NSE:ENTERO:
EV-to-EBITDA: 27.12 (near median its 10-year median of 25.24)
GF Value™: ₹1,760.51 vs. price of ₹1,898.40 (7.8% above fair value)
Industry Position: 219.2% above the Medical Distribution median (#90 of 100)
No single metric tells the full story. See the NSE:ENTERO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.
64GF Score
Get the complete analysis for NSE:ENTERO
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ENTERO has been successfully added to your 
